California is changing how testosterone prescriptions appear in the state CURES database on January 1, 2026. Patients should understand what disappears from CURES, what stays in their pharmacy and prescriber records, and why keeping an accurate medication list remains important.
California patients who use prescription testosterone will see an important CURES change at the start of 2026. Assembly Bill 82 changes what is sent to California’s Controlled Substance Utilization Review and Evaluation System. Beginning January 1, pharmacies and other dispensers must not report testosterone dispensing to CURES. For patients, the most useful takeaway is simple: the statewide monitoring database is changing, but your prescription still belongs on the medication list you share with your prescriber, pharmacist and other health professionals.
Quick Answer
Starting January 1, 2026, testosterone dispensing will no longer be reported to California CURES. That does not mean your pharmacy record, prescriber’s chart or insurance history disappears, and it does not change testosterone’s federal controlled-substance status. Keep testosterone on your current medication list, plan refills normally, and tell each prescriber and pharmacy about the medicines you use rather than assuming CURES will show the full picture.
What Changes for Testosterone in CURES on January 1, 2026
CURES is California’s prescription drug monitoring program. It is used by authorized health care practitioners, pharmacists and certain government users to review controlled-substance dispensing information under state law.
Under Assembly Bill 82, dispensers must stop reporting testosterone and mifepristone dispensations to CURES effective January 1, 2026. The California Department of Justice is also required to remove existing testosterone and mifepristone records from CURES by January 1, 2027.
For someone taking testosterone, this means a future CURES report will no longer function as a complete history of testosterone dispensing. A clinician or pharmacist reviewing CURES should not assume the absence of testosterone means a patient is not using it.
CURES is not your complete medical or pharmacy record.
The January change concerns what is sent to the statewide CURES database. It does not automatically remove the prescription from the dispensing pharmacy’s records, the prescriber’s chart, the patient’s medication list or an insurer’s claim history.
What Does Not Change About a Testosterone Prescription?
The CURES reporting exemption is narrow. It changes the state monitoring database, not the medication itself. Testosterone remains a federally controlled substance, and pharmacies and prescribers must continue following the laws and professional requirements that apply to prescribing and dispensing it.
Patients should continue using the prescription exactly as directed by their prescriber and should follow the same refill, storage and pharmacy instructions they were given before January 1. The new law is not a reason to change a dose, refill earlier than permitted or stop treatment.
01
CURES Reporting Changes
New testosterone dispensations are no longer sent to CURES beginning January 1, 2026, and older CURES records are scheduled for removal under state law.
02
Your Prescription Records Remain
The dispensing pharmacy and prescriber still maintain records relevant to your prescription. Continue bringing current medication and insurance information to visits.
Keep Your Pharmacy Record Current
Bring an Updated Medication List to Your Next Pharmacy Visit
La Quinta Pharmacy can update the medication information you provide and help with routine questions about your current prescription, refill status, insurance information or a prescription transfer.
Preparing for Testosterone Refills and Pharmacy Visits in 2026
The CURES change does not create a universal new refill schedule. Continue checking the prescription label and speaking with the pharmacy about the refill status of your specific prescription. Controlled-substance requirements, prescription directions, remaining authorization from the prescriber and insurance rules can all affect when a refill can be processed.
If you are changing pharmacies, do not assume that the absence of testosterone in CURES makes a transfer automatic. Controlled-substance transfer rules can differ from ordinary prescription transfers, and the receiving pharmacy may need specific prescription information or prescriber involvement.
When insurance changes in January, bring the current member card or electronic coverage information before the first 2026 claim. A claim rejection is an insurance or processing issue; it is separate from the question of whether a dispensation is reported to CURES.
If You Use More Than One Prescriber or Pharmacy
Patients sometimes receive care from a primary clinician, specialist, urgent-care service or another practice at different times of the year. If those clinicians do not share the same electronic health record, each office may have a different medication list.
After January 1, do not rely on CURES to fill that information gap for testosterone. Tell each prescriber that testosterone is part of your current medication regimen and identify the prescribing clinician when asked. The same principle applies when establishing care at a new pharmacy: provide an accurate medication list and the current prescription information rather than assuming a statewide database will supply it.
If you are unsure which information a pharmacy needs, call before the refill is urgent. That gives the pharmacy time to review the prescription record and explain what can be handled at the pharmacy and what may require contact with the prescriber.
Your Year-End Testosterone Prescription Checklist
A short review in December can make the first pharmacy visit of 2026 more straightforward.
What La Quinta Pharmacy Can Help With
La Quinta Pharmacy can answer routine questions about a prescription on file, identify refill status, update insurance information, review the medication information you provide and explain what information may be needed when moving a prescription to the pharmacy.
The pharmacy cannot change California law, alter a CURES record or make decisions for a prescriber. Questions about why a clinician checks CURES, professional consultation requirements or changes to a treatment plan should be addressed to the appropriate prescriber or licensing authority.
Frequently Asked Questions
Will testosterone prescriptions stop appearing in California CURES on January 1, 2026?
New testosterone dispensations must not be reported to CURES beginning January 1, 2026. California law also requires the Department of Justice to remove existing testosterone records from CURES by January 1, 2027. This change affects the CURES database, not every medical, pharmacy or insurance record related to the prescription.
Does this mean testosterone is no longer a controlled substance?
No. The California CURES reporting change does not remove testosterone from its federal controlled-substance classification. Pharmacies and prescribers still have to follow the requirements that apply to prescribing and dispensing testosterone. Patients should continue following their prescription directions and normal refill process.
Will my pharmacy still have a record of my testosterone prescription?
Yes. CURES is separate from the dispensing pharmacy’s own prescription record. The pharmacy continues to maintain records required for prescriptions it dispenses. A prescriber’s medical chart and an insurer’s claims records are also separate systems from CURES.
Should I tell a new doctor that I take testosterone if it is no longer in CURES?
Yes. Keep testosterone on the medication list you provide to health professionals. After January 1, a CURES report should not be treated as a complete source for testosterone use, so direct medication reconciliation remains important when you see a new clinician or receive care in a different setting.
Does the CURES change affect when I can refill testosterone?
The reporting change itself does not create a universal new refill date. Refill timing can depend on the prescription, applicable controlled-substance rules, prescriber authorization and insurance processing. Contact the pharmacy about the status of your specific prescription rather than assuming CURES reporting determines refill eligibility.
Have a Testosterone Prescription Question?
Contact La Quinta Pharmacy about refill status, insurance updates, medication-list information or routine pharmacy questions involving a current testosterone prescription.